scholarly article | Q13442814 |
P50 | author | Giovanni Guaraldi | Q38548492 |
Marco Floridia | Q42246831 | ||
Enrica Tamburrini | Q57385925 | ||
Antonella Vimercati | Q57385937 | ||
P2093 | author name string | A Degli Antoni | |
A Maccabruni | |||
M Ravizza | |||
C Tibaldi | |||
E Ferrazzi | |||
S Alberico | |||
Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy | |||
G Anzidei | |||
P2860 | cites work | The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States | Q73352741 |
Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force | Q22241142 | ||
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group | Q28239283 | ||
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission | Q33958839 | ||
Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy | Q34387805 | ||
The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies | Q34502812 | ||
Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial | Q34719306 | ||
Pregnancy and HIV infection: A european consensus on management | Q35024297 | ||
Prenatal HIV testing and antiretroviral prophylaxis at an urban hospital--Atlanta, Georgia, 1997-2000. | Q39672868 | ||
Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000). | Q43956302 | ||
Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy | Q44404808 | ||
Combination antiretroviral therapy in 100 HIV-1-infected pregnant women | Q44979565 | ||
Pregnancy-related changes in the longer-term management of HIV-infected women in Europe | Q47862350 | ||
Expanded screening for HIV in the United States--an analysis of cost-effectiveness. | Q50756519 | ||
Vertical transmission of HIV-1: maternal immune status and obstetric factors. The European Collaborative Study. | Q50984331 | ||
How to treat without the need to deliver continuous HIV suppression? 9th Conference on Retroviruses and Opportunistic Infections. February 24-28, 2002 - Seattle | Q56938342 | ||
P433 | issue | 5 | |
P921 | main subject | Italy | Q38 |
human pregnancy | Q11995 | ||
pregnant person | Q104720811 | ||
P304 | page(s) | 1120-1127 | |
P577 | publication date | 2006-03-02 | |
P1433 | published in | Epidemiology and Infection | Q5382708 |
P1476 | title | Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy | |
P478 | volume | 134 |
Q35867233 | A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes |
Q36878888 | A review of reproductive health research, guidelines and related gaps for women living with HIV. |
Q39672296 | Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series. |
Q42260917 | Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011. |
Q45842769 | Body mass index and weight gain in pregnant women with HIV: a national study in Italy |
Q44273652 | Declining HCV seroprevalence in pregnant women with HIV. |
Q42994549 | Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART. |
Q34014081 | Estimates of the number of people living with HIV in Italy |
Q33718592 | Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015 |
Q35861475 | Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment |
Q56967541 | Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy |
Q40379966 | HBV coinfection is associated with reduced CD4 response to antiretroviral treatment in pregnancy |
Q31011972 | HCV-HIV coinfected pregnant women: data from a multicentre study in Italy |
Q44017849 | Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine |
Q36043371 | Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009. |
Q42255965 | Pregnancy outcomes in HIV-infected women of advanced maternal age. |
Q35445035 | Pregnancy outcomes in women with advanced HIV infection in Italy |
Q38676975 | Pregnant with HIV before age 25: data from a large national study in Italy, 2001-2016. |
Q39078742 | Rate, correlates and outcomes of repeat pregnancy in HIV-infected women. |
Q85189789 | Social and behavioural characteristics of a sample of AIDS Help-Line users never tested for HIV in Italy |
Q50142088 | Voluntary pregnancy termination among women with HIV in the HAART era (2002-2008): a case series from a national study |